3 recruiting, 1 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 3, Completed 1 |
Follow Reboxetine: new trials by email Literature Review of Reboxetine trials Research Report on Reboxetine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD methylphenidate (Ritalin®), Reboxetine, Placebo - PTSD, Posttraumatic Stress Disorder | Phase 2 | Recruiting | University of Haifa | 160 | 2026-08-01 | 2026-08-18 |
| Reboxetine for Sleep Apnoea After ENT Surgery Reboxetine 4 MG Oral Tablet, Placebo - Sleep Apnea, Obstructive | Phase 2 | Recruiting | Flinders University | 20 | 2023-08-10 | 2024-10-03 |
| Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD Methylphenidate, Reboxetine, Placebo - Posttraumatic Stress Disorder | Phase 2 | Recruiting | University of Haifa | 53 | 2022-06-01 | 2026-08-11 |
| Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT) AXS-12 (Reboxetine), Placebo - Narcolepsy, Cataplexy Narcolepsy | Phase 2 | Completed | Axsome Therapeutics, Inc. | 21 | 2019-04-05 | 2026-06-15 |
Stress Disorders, Post-Traumatic (2) · Attention Deficit Disorder with Hyperactivity (1) · Cataplexy (1) · Disorders of Excessive Somnolence (1) · Emotional Regulation (1) · Narcolepsy (1) · Sleep Apnea, Obstructive (1)
University of Haifa (2) · Axsome Therapeutics, Inc. (1) · Flinders University (1)
Israel (2) · Australia (1) · United States (1)
Avi Avital, PhD (2) · Batya Engel-Yeger, PhD (1) · Danny J. Eckert, PhD (1) · Inbal Brenner, MD (1) · Tsipi Milman, MD (1)